iShares MSCI ACWI ex U.S. ETF (ACWX)
| Assets | $11.42B |
| Expense Ratio | 0.32% |
| PE Ratio | 18.20 |
| Shares Out | 151.20M |
| Dividend (ttm) | $1.90 |
| Dividend Yield | 2.50% |
| Ex-Dividend Date | Dec 16, 2025 |
| Payout Frequency | Semi-Annual |
| Payout Ratio | 43.86% |
| Volume | 1,259,677 |
| Open | 75.56 |
| Previous Close | 74.78 |
| Day's Range | 75.41 - 75.82 |
| 52-Week Low | 57.62 |
| 52-Week High | 76.09 |
| Beta | 0.76 |
| Holdings | 1769 |
| Inception Date | Mar 26, 2008 |
About ACWX
Fund Home PageThe iShares MSCI ACWI ex U.S. ETF (ACWX) is an exchange-traded fund that is based on the MSCI AC World ex USA index. The fund tracks the performance of a market-cap-weighted index of international stocks. It captures 85% of the publicly available market, thus excluding small-caps. ACWX was launched on Mar 26, 2008 and is issued by BlackRock.
Top 10 Holdings
15.32% of assets| Name | Symbol | Weight |
|---|---|---|
| Taiwan Semiconductor Manufacturing Company Limited | 2330 | 4.81% |
| Samsung Electronics Co., Ltd. | 005930 | 2.34% |
| SK hynix Inc. | 000660 | 1.65% |
| ASML Holding N.V. | ASML | 1.58% |
| Tencent Holdings Limited | 0700 | 1.04% |
| Alibaba Group Holding Limited | 9988 | 0.83% |
| HSBC Holdings plc | HSBA | 0.82% |
| Roche Holding AG | ROP | 0.77% |
| AstraZeneca PLC | AZN | 0.75% |
| Novartis AG | NOVN | 0.73% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 16, 2025 | $1.04876 | Dec 19, 2025 |
| Jun 16, 2025 | $0.84676 | Jun 20, 2025 |
| Dec 17, 2024 | $0.76733 | Dec 20, 2024 |
| Jun 11, 2024 | $0.78393 | Jun 17, 2024 |
| Dec 20, 2023 | $0.71407 | Dec 27, 2023 |
| Jun 7, 2023 | $0.79785 | Jun 13, 2023 |
Performance
ACWX had a total return of 35.14% in the past year, including dividends. Since the fund's inception, the average annual return has been 4.93%.
News
BlackRock's Model Shift: Scaling Active ETFs Ahead of Exchange
Actively managed ETFs in the U.S. gathered $73 billion of new money in February and, thanks to model allocation changes made by BlackRock last week, are poised for another strong month. BlackRock's st...
The U.S. is not the place to be for investors in 2026 so far. Where they are turning to for gains
The biggest winners this year are all abroad. Emerging markets stocks represented by the iShares MSCI Emerging Markets ETF (EEM) are higher by more than 6% this year, while all non-U.S. equities in th...
International Stocks Are Outperforming. Investment Pros Weigh the ‘Sell America' Trade.
Investment advisors agree that it would be foolish for clients not to own foreign shares. The question is what to buy now and how much.
ETFs are on pace to take in a record $1.3 trillion in 2025. Here's where the money's going.
Investors keep piling into exchange-traded funds — with the latest monthly flow data reflecting some limit to their appetite for risk in the U.S., as well as a desire to diversify internationally.
International stocks dubbed best trade for 5 years as Israel, Iran violate ceasefire
Global financial markets remain in focus this week after the US launched airstrikes on three Iranian nuclear facilities over the weekend, to which Tehran retaliated with an attack on the US bases in Q...
French stocks are pressuring widely held equities indexes. Should you buy the dip?
French stocks have taken a beating on election worries, dragging down popular equity indexes focused on countries outside the U.S.
Five stocks for investors who want to broaden their growth horizons beyond the S&P 500
U.S. investors know how successful a strategy of investing in the S&P 500 through an index fund has been, especially as large technology companies have led such strong growth over the past decade. But...
Strategists: Look Abroad for Stock Investments in 2023
Stocks in Europe and emerging markets are cheap compared to those in the U.S., but that's not the only draw.